OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BAP1 in cancer: epigenetic stability and genome integrity
Sabrina Caporali, Alessio Butera, Ivano Amelio
Discover Oncology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

The molecular code of kidney cancer: A path of discovery for gene mutation and precision therapy
Deqian Xie, Guandu Li, Zhonghua Zheng, et al.
Molecular Aspects of Medicine (2025) Vol. 101, pp. 101335-101335
Open Access | Times Cited: 2

Nuclear localization of BRCA1-associated protein 1 is important in suppressing hepatocellular carcinoma metastasis via CTCF and NRF1/OGT axis
Xiaoyu Xie, Yu‐Man Tsui, Xin Zhang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines – A Pilot Study
Martina C. Herwig‐Carl, Amit Sharma, Verena Tischler, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 2, pp. 27-27
Open Access | Times Cited: 2

A comprehensive review of PRAME and BAP1 in melanoma: Genomic instability and immunotherapy targets
Alaa A. A. Aljabali, Murtaza M. Tambuwala, Mohamed El‐Tanani, et al.
Cellular Signalling (2024), pp. 111434-111434
Closed Access | Times Cited: 2

YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations
Richard Cunningham, Siyang Jia, Krishna Pinganksha Purohit, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 5

Deubiquitinase BAP1 regulates stability of BRCA1 protein and inactivates the NF-κB signaling to protect mice from sepsis-induced acute kidney injury
Shu Luo, Junzuo Gong, Shiqiao Zhao, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110621-110621
Open Access | Times Cited: 5

Major response of a peritoneal mesothelioma to nivolumab and ipilimumab: a case report, molecular analysis and review of literature
Marie-Florence Reveneau, Julien Masliah‐Planchon, Manuel Delgado‐Fernández, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1

Understanding the intersection between placental development and cancer: Lessons from the tumor suppressor BAP1
Paula Doria-Borrell, Vicente Pérez-García
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1

BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13
Carmen Martínez-Fernández, Sweta Jha, Elisabet Aliagas, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 929-929
Open Access | Times Cited: 3

Newest therapeutic strategies impacting on rarest thoracic malignancies: the clinical case report of biphasic pleural mesothelioma.
Federica Pellicioli, Luca Sala, Francesca Colonese, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e36306-e36306
Open Access

Second Primary Cancers in a Population-Based Mesothelioma Registry
Carolina Mensi, Simona Stella, Barbara Dallari, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1746-1746
Open Access | Times Cited: 1

Page 1

Scroll to top